# 37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof.

37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof., “Amendment to add or replace a “Sequence Listing” and CRF copy thereof”, is a CFR section of [37 CFR Part 1, Subpart G, Subject Group: Application Disclosures Containing Nucleotide and/or Amino Acid Sequences—Application Disclosures Containing Nucleotide and/or Amino Acid Sequences](https://ontology.bommaritollc.com/id/01a0f0a7-936f-731c-9998-857c49f181b2); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd>

Within: [Title 37—Patents, Trademarks, and Copyrights](https://ontology.bommaritollc.com/id/01a0f0a7-92b7-7727-8bd2-ca5b54f0b3e5) › [37 CFR Chapter I—UNITED STATES PATENT AND TRADEMARK OFFICE, DEPARTMENT OF COMMERCE](https://ontology.bommaritollc.com/id/01a0f0a7-9318-77c9-86b1-3e7c770eed43) › [37 CFR Chapter I, Subchapter A—GENERAL](https://ontology.bommaritollc.com/id/01a0f0a7-931a-7100-bcfe-e11e00e2e100) › [37 CFR Part 1—Rules of practice in patent cases](https://ontology.bommaritollc.com/id/01a0f0a7-9487-7184-b5d4-ea57aecf9f81) › [37 CFR Part 1, Subpart G—Biotechnology Invention Disclosures](https://ontology.bommaritollc.com/id/01a0f0a7-936d-73ed-9bc0-72efbca63167) › [37 CFR Part 1, Subpart G, Subject Group: Application Disclosures Containing Nucleotide and/or Amino Acid Sequences—Application Disclosures Containing Nucleotide and/or Amino Acid Sequences](https://ontology.bommaritollc.com/id/01a0f0a7-936f-731c-9998-857c49f181b2)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 37 CFR 1.825](https://ontology.bommaritollc.com/id/01a0f0a7-96d3-7381-8ed6-5f3e2f999b95)
- `eli:cites`:
  - [37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications.](https://ontology.bommaritollc.com/id/01a0f0a7-95b1-76dc-9566-e3d5917c6ea6)
  - [37 CFR 1.77 Arrangement of application elements.](https://ontology.bommaritollc.com/id/01a0f0a7-95ca-70b2-ac09-615e6f93ad77)
  - [37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications.](https://ontology.bommaritollc.com/id/01a0f0a7-96cd-7703-a7ba-3936705cb80a)
  - [37 CFR 1.824 Form and format for a nucleotide and/or amino acid sequence submission as an ASCII plain text file.](https://ontology.bommaritollc.com/id/01a0f0a7-96d1-77f7-88f7-df8de2c7fcc8)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title37-vol1](https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39d04432068)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0a7-a0f3-76a2-938b-2a3338cdb9be)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d1-3b4c-775c-9826-ca6189ddb4a2)
  - [evidence from https://www.govinfo.gov/link/cfr/37/1?sectionnum=825&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-d228-70f5-b612-cd6d408f0c8d)
- `schema:isPartOf`: [37 CFR Part 1, Subpart G, Subject Group: Application Disclosures Containing Nucleotide and/or Amino Acid Sequences—Application Disclosures Containing Nucleotide and/or Amino Acid Sequences](https://ontology.bommaritollc.com/id/01a0f0a7-936f-731c-9998-857c49f181b2)
- `schema:legislationIdentifier`: 37 CFR 1.825
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Amendment to add or replace a “Sequence Listing” and CRF copy thereof
- `schema:url`: [https://www.govinfo.gov/link/cfr/37/1?sectionnum=825&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/37/1?sectionnum=825&year=mostrecent&link-type=details)
- `skos:prefLabel`: 37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/37/1?sectionnum=825&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title37-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (5; `eli:cites`):
  - [37 CFR 1.121 Manner of making amendments in applications.](https://ontology.bommaritollc.com/id/01a0f0a7-95f0-75d4-858d-588737e0fc57)
  - [37 CFR 1.173 Reissue specification, drawings, and amendments.](https://ontology.bommaritollc.com/id/01a0f0a7-9617-7739-b63c-52f06925ce47)
  - [37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications.](https://ontology.bommaritollc.com/id/01a0f0a7-95b1-76dc-9566-e3d5917c6ea6)
  - [37 CFR 1.530 Statement by patent owner in ex parte reexamination; amendment by patent owner in ex parte or inter partes reexamination; inventorship change in ex parte or inter partes reexamination.](https://ontology.bommaritollc.com/id/01a0f0a7-9697-7203-ad77-0522560d7488)
  - [37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications.](https://ontology.bommaritollc.com/id/01a0f0a7-96cd-7703-a7ba-3936705cb80a)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd)
Cite as: 37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f0a7-96d2-7265-ab9d-e39e2cf496cd
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
